Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care-testing (poct) market from 2025–2034 with trusted insights from The Business Research Company

How Is The Point-Of-Care-Testing (POCT) Market Expected To Grow In Terms Of Size?

The point-of-care-testing (POCT) market size has experienced swift expansion in recent years. It is anticipated to increase from $45.45 billion in 2024 to $50.79 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. The reasons for this growth in previous periods include a heightened emphasis on personalized medicine, increased financial commitments to healthcare infrastructure, a rise in urgent care incidents, the expanding utilization of point-of-care molecular testing, and the growing incorporation of artificial intelligence in diagnostic methods.

The market for point-of-care-testing (POCT) is projected to experience swift expansion over the coming years. This market is anticipated to reach $78.19 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this growth during the projection period include a heightened demand for personalized medicine, the expansion of telehealth and remote monitoring practices, improved access to healthcare in developing regions, the broader utilization of POCT in unconventional environments, and the increasing uptake of wearable diagnostic tools. Key trends foreseen in the forecast timeframe encompass improvements in multiplex testing platforms, the creation of portable molecular diagnostic equipment, breakthroughs in smartphone-dependent diagnostic instruments, progress in connectivity and data integration, and the formulation of AI-driven POCT remedies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27391&type=smp

What Market Forces Are Contributing To The Growth Of The Point-Of-Care-Testing (POCT) Market?

The point-of-care-testing (POCT) market is projected to expand due to the rising integration of telemedicine. Telemedicine involves providing healthcare services from a distance, utilizing digital communication tools like video conferencing, telephone calls, or secure messaging platforms. Its widespread use stems from the growing need for accessible, prompt, and touchless medical consultations, a trend significantly bolstered by the COVID-19 pandemic. Point-of-care testing (POCT) complements telemedicine by delivering swift and dependable diagnostic outcomes that can be immediately transmitted to distant medical professionals. An illustrative example comes from February 2023: a survey conducted between July 12 and August 22, 2022, by Rock Health, a US-based health technology company, involved 8,014 respondents. The findings showed that 76% of individuals aged over 55 had utilized telemedicine, and 80% of all participants indicated they had accessed care through telemedicine at some point, marking an 8% increase from 72% in 2021. Consequently, the expanding use of telemedicine is fueling the expansion of the point-of-care-testing (POCT) market.

How Is The Point-Of-Care-Testing (POCT) Market Segmented Across Key Categories?

The point-of-care-testing (POCT) market covered in this report is segmented

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

What Key Trends Are Driving Growth In The Point-Of-Care-Testing (POCT) Market?

Leading firms within the point-of-care-testing (POCT) market are concentrating their efforts on creating novel products, like blood glucose management solutions, aimed at enhancing diagnostic speed, precision, and patient results in close proximity to patients. These blood glucose management solutions encompass instruments, devices, and systems employed for monitoring, tracing, and regulating blood sugar levels to manage conditions like diabetes. An example is the launch of the Cobas pulse system in January 2022 by F. Hoffmann-La Roche AG, a pharmaceutical company based in Switzerland. The Cobas pulse system presents an advanced connected platform, integrating sophisticated point-of-care blood glucose testing with the functionalities of smart devices. This system facilitates smooth integration with hospital information technology (IT) systems, allowing for automated result transfers and immediate access to clinical data. Furthermore, the device supports healthcare applications, which improve decision-making assistance and operational efficiency directly with the patient.

Who Are The Major Stakeholders Operating In The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (POCT) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Zoetis Inc., BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, SiPhox Inc., and Sinocare Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

How Do Regional Dynamics Influence The Point-Of-Care-Testing (POCT) Market Performance?

North America was the largest region in the point-of-care testing (POCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (POCT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27391&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2025, By The Business Research Company

Precast Concrete Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Modular And Prefabricated Nonresidential Building Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Ready Mix Concrete Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model